Biotech

All Articles

Orion to utilize Aitia's 'electronic identical twins' to find new cancer medicines

.Finnish biotech Orion has snooped prospective in Aitia's "electronic double" specialist to build ne...

Windtree's surprise med brings up blood pressure in most current period 2 gain

.While Windtree Rehabs has struggled to develop the financial origins required to survive, a period ...

2 cancer cells biotechs merge, producing global footprint

.OncoC4 is taking AcroImmune-- as well as its internal medical manufacturing abilities-- under its o...

Amgen records first stage 3 gain for $400M dermatitis drug

.Amgen has shared (PDF) the 1st phase 3 data on its $400 million eczema medicine, linking the anti-O...

Biogen, UCB report phase 3 lupus win after falling short earlier trial

.Biogen and also UCB's bank on developing right into period 3 astride a broken study tries to have a...

Aptadir hopes brand-new RNA inhibitors can reverse complicated cancers

.Italian biotech Aptadir Therapeutics has introduced with the pledge that its pipeline of preclinica...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending out stock up

.Wave Life Sciences has actually met its goal in a Duchenne muscle dystrophy (DMD) research, positio...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma fold,...

Achilles drops cell therapy system, braces for cutbacks after skipping 'industrial stability' targets

.Achilles Therapeutics has actually torn up its approach. The English biotech is knocking off on its...

Aligos declares phase 2 MASH win, slashing liver excess fat approximately 46%

.Aligos Rehabs is declaring a midstage succeed in metabolic-dysfunction connected steatohepatitis (M...